144 (Dutrebis lamivudine 150 mg / raltegravir 300 mg)
Generic Name: lamivudine/raltegravir
Pill with imprint 144 is Green, Elliptical / Oval and has been identified as Dutrebis lamivudine 150 mg / raltegravir 300 mg. It is supplied by Merck & Co., Inc..
Dutrebis is used in the treatment of hiv infection and belongs to the drug class antiviral combinations. Risk cannot be ruled out during pregnancy. Dutrebis lamivudine 150 mg / raltegravir 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 144
- Generic Name:
- lamivudine 150 mg / raltegravir 300 mg
- Elliptical / Oval
- Prescription only
- Drug Class:
- Antiviral combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Merck & Co., Inc.
- National Drug Code (NDC):
More about Dutrebis (lamivudine / raltegravir)
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.